Infrastructure for healthcare personalization

GenX allows local genetic testing companies to interact with CROs for research and clinical trials, and to cooperate with each other for a Europe‑wide ancestry search.

How data helps personalize healthcare
scheme scheme
scheme-2 scheme-2

Per year is the average
expenditure on finding
patients in the USA

Most of them do not have an access
to personal treatments
Small genetic companies
Trying to monetize the database
somewhere in future

How it works

GenX delivers open source software that can be integrated with the data provider’s stores and provides pharmaceutical companies with combined access to them.

Cryptography and blockchain provide reliability and transparency.


Pharma companies and Research institutions

Global genetics and phenotype database in Europe, Asia

Multiple decrease time and costs of finding participants for clinical trials

Additional data source for all phases of drug discovery

Genetics companies and clinics

Make additional profit by providing data buyers with access to collected data

Provide a better ancestry and predisposition service to their clients due to global database


Get wide and personalized access to clinical trials

Get access to personalized medicines


  • Kirill Petrenko

    CEO and co-founder

    Co-founder of MaxyGen
    genetic device company

    Co-founder of Genotek
    genetic testing & analysis company

    Startup accelerators:
    – StartUp Sauna (SV, USA),
    – StarTau (Tel Aviv, Israel)

    MSU, Ms in Math

  • Konstantin Stiskin

    Creator and co-founder

    Genotek board member.
    Venture Partner at Target Global,
    more than 20 deals in other VCs
    and PEs.

    More than 40 deals and 10 exits
    Vast experience in VC and as
    business-angel, including:
    – Runa Capital
    – Phenomen Ventures
    – FinSight Venture funds

    HSE and Hult BS

  • Ilya Sachkov

    Partner (cybersecurity
    and personal data)

    Founder of Group IB, a leading
    cyber security company.
    Member of cybercrime expert
    committees in the Council of
    Europe and the OSCE.
    MGTU Bauman

  • BioCity Group

    Life Science Incubator

    BioCity provides support
    for startups solving
    challenges in healthcare
    that affect us, globally.

    GenX is a resident since 2018.

Be part of the consortium of European genetics companies